These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 8718526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D.
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [Abstract] [Full Text] [Related]

  • 11. Liposome-mediated adenomatous polyposis coli gene therapy: a novel anti-adenoma strategy in multiple intestinal neoplasia mouse model.
    Lee J, Hargest R, Wasan H, Phillips RK.
    Dis Colon Rectum; 2004 Dec; 47(12):2105-13. PubMed ID: 15657662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
    Ruiz-Ponte C, Vega A, Carracedo A, Barros F.
    Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
    [Abstract] [Full Text] [Related]

  • 15. Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.
    Cormier RT, Dove WF.
    Cancer Res; 2000 Jul 15; 60(14):3965-70. PubMed ID: 10919675
    [Abstract] [Full Text] [Related]

  • 16. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
    Abal M, Obrador-Hevia A, Janssen KP, Casadome L, Menendez M, Carpentier S, Barillot E, Wagner M, Ansorge W, Moeslein G, Fsihi H, Bezrookove V, Reventos J, Louvard D, Capella G, Robine S.
    Gastroenterology; 2007 Jun 15; 132(7):2448-58. PubMed ID: 17570218
    [Abstract] [Full Text] [Related]

  • 17. Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice.
    Steffensen IL, Schut HA, Nesland JM, Tanaka K, Alexander J.
    Mutat Res; 2006 Dec 10; 611(1-2):71-82. PubMed ID: 16962818
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K, Baudino TA.
    Mol Cancer Res; 2007 Dec 10; 5(12):1296-303. PubMed ID: 18171987
    [Abstract] [Full Text] [Related]

  • 19. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
    van Wyk R, Slezak P, Hayes VM, Buys CH, Kotze MJ, de Jong G, Rubio C, Dolk A, Jaramillo E, Koizumi K, Grobbelaar JJ.
    Genes Chromosomes Cancer; 2000 Feb 10; 27(2):202-8. PubMed ID: 10612810
    [Abstract] [Full Text] [Related]

  • 20. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia.
    Silverman KA, Koratkar R, Siracusa LD, Buchberg AM.
    Genome Res; 2002 Jan 10; 12(1):88-97. PubMed ID: 11779834
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.